Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway (2015)
Attributed to:
Confidence in Concept 2012 - Imperial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1538-8514.pi3k14-a47
Publication URI: http://dx.doi.org/10.1158/1538-8514.pi3k14-a47
Type: Journal Article/Review
Parent Publication: Molecular Cancer Therapeutics
Issue: 7_Supplement